Wegovy Reviews: What People on Semaglutide Actually Experience

Wegovy is a once-weekly injectable medicine containing semaglutide, a GLP-1 receptor agonist. It works by acting on appetite-regulating pathways in the body, and many people report a noticeable reduction in hunger and "food noise" — the persistent preoccupation with eating that can make weight management difficult.

Commonly reported positives

• Reduced appetite: Many people describe feeling satisfied with smaller portions, sometimes quite quickly after starting.
• Lower food noise: A quieter mental preoccupation with food is one of the most frequently mentioned changes, particularly in the earlier weeks.
• Gradual weight changes: Progress is typically slow and non-linear — most accounts describe a journey of weeks and months rather than rapid results.

Commonly reported challenges

• Gastrointestinal symptoms: Nausea, constipation, and indigestion are among the most frequently mentioned side effects, especially around dose changes. Many people find these ease over time.
• Fatigue: Some people report low energy in the early weeks of treatment or after a dose increase.
• Adjustment period: The starting dose (0.25 mg) is intentionally low to allow the body to adjust — reviews at this stage often differ significantly from those later in a titration schedule.

If you are reading reviews specifically about the 0.5 mg stage, bear in mind that this is still an early phase for most people; experiences at this point often reflect an ongoing adjustment rather than the full picture of what the medicine does over time.

For a broader look at how semaglutide and tirzepatide compare as described by people taking them, see what people report on Mounjaro — or explore more Wegovy user experiences for additional perspectives. If you are curious about the clinical and factual differences between the two medicines, our Wegovy overview covers the key facts.

Reading other people's reviews is a natural starting point, but the most meaningful account of Wegovy will always be your own — and that is where GLP Trackr is built to help.

The most relevant feature here is side-effect tracking. You can log symptoms like nausea, fatigue, or digestive changes as they happen, and the app surfaces patterns over time — for example, whether symptoms cluster around injection day or ease as the week goes on. That kind of personalised record is far more useful than comparing yourself to a stranger's review online, and it gives you something concrete to discuss with your prescriber at your next appointment.

Alongside that, the daily check-in lets you note mood, energy, food noise, and sleep in under a minute each morning, building a picture of how you are feeling across weeks rather than just on a difficult day. The weight and progress charts then show your trajectory in context — a helpful reality check when progress feels slower than other people's reviews suggest it should be.

For a wider look at what people on tirzepatide report alongside those on semaglutide, the Mounjaro hub is a useful reference point.

If anything you experience feels severe, persistent, or worrying at any point — including symptoms you have read about in other people's reviews — contact your healthcare professional promptly. GLP Trackr helps you record what is happening so you can have an informed conversation; it is not a substitute for their guidance, and any decisions about your treatment belong with your prescriber or doctor.

Ready to build your own record? GLP Trackr is free to try for seven days — download it on the App Store or Google Play and start logging from your very next dose.